NATIONAL BANK OF CANADA /FI/ - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,381
-24.1%
1,1360.0%0.00%
Q2 2023$11,036
+74.8%
1,136
+97.2%
0.00%
Q1 2023$6,313
+172.7%
576
+7.5%
0.00%
Q4 2022$2,315
-22.8%
536
+39.9%
0.00%
Q3 2022$3,000
-25.0%
3830.0%0.00%
Q2 2022$4,000
-20.0%
3830.0%0.00%
Q1 2022$5,000
-44.4%
3830.0%0.00%
Q4 2021$9,0003830.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders